09/07/23 9:00 AMNasdaq : MEDS acquisitionlow floatTRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, Is Gearing Up To Make Big Splashes In the $151 Billion Snacks Industry with its Acquisition of The Urgent Company Inc.NEW YORK, NY / ACCESSWIRE / September 7, 2023 / TRxADE Health, Inc. (NASDAQ:MEDS), known for its pharmaceutical exchange platform, has recently merged with Superlatus, Inc., a leading food technology and distribution company. The combined entity has now announced a binding agreement to acquire TheRHEA-AIvery positive
08/24/23 8:05 AMNasdaq : MEDS low floatSuperlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot BrandSuperlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc. (NASDAQ: MEDS) and is gearing up to revolutionize the snack industry. The Company has unveiled its intent to introduce pulse-based twisted protein snacks throughRHEA-AIneutral
08/22/23 8:05 AMNasdaq : MEDS acquisitionlow floatSuperlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.TRxADE HEALTH,RHEA-AIneutral
08/14/23 10:25 AMNasdaq : MEDS low floatTRxADE HEALTH, Inc. Announces Extension of Form 10-Q FilingTRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file its Quarterly Report on Form 10-Q for Q2 pursuant to a Form 12b-25 filed with the SEC. The Company isRHEA-AIneutral
08/03/23 9:05 AMNasdaq : MEDS managementacquisitionlow floatNewly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management TeamTRxADE HEALTH, Inc (NASDAQ: MEDS), parent company of pharmaceutical B2B exchange platform, which recently merged withRHEA-AIneutral
07/31/23 4:15 PMNasdaq : MEDS conferencesearningslow floatTRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m. Eastern TimeTAMPA, FL / ACCESSWIRE / July 31, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for theRHEA-AIneutral
07/31/23 8:35 AMNasdaq : MEDS acquisitionlow floatTRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced the closing of the previously announced acquisition of Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products andRHEA-AIneutral
07/14/23 4:30 PMNasdaq : MEDS acquisitionlow floatTRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, announced today that it entered into an amended and restated merger agreement with Superlatus, Inc. (“Superlatus”), a U.S.-based holding company of food productsRHEA-AIneutral
06/30/23 8:05 AMNasdaq : MEDS acquisitionlow floatSuperlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive Merger Agreement to Create a Global Strategic Platform for Food and Healthy Snack Marketplace and DistributionSuperlatus, Inc. (“Superlatus”), a U.S.-based holding company of food products and distribution capabilities, announced today that it has signed a definitive agreement to be acquired by TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceuticalRHEA-AIneutral
06/23/23 4:40 PMNasdaq : MEDS low floatTRxADE HEALTH, Inc. Issues Correction to Press Release Announcing its Anticipated Combination with Superlatus, Inc. (Correction Notice)TRxADE HEALTH, Inc. (NASDAQ:MEDS) (“TRxADE”), a pharmaceutical exchange platform, today announced a correction to its press release issued on Friday, June 23, 2023, 8:05 U.S. Eastern Time, entitled “Superlatus, Inc. to Combine with TRxADE HEALTH, Inc.,RHEA-AIneutral